Video interviews of experts in the field reviewing top abstracts from the 2022 ASCO Annual Meeting.
EP. 1: Dr. Chang summarizes key bladder cancer research from ASCO 2022
Sam S. Chang, MD, MBA, recaps 5 presentations from the 2022 American Society of Clinical Oncology Annual Meeting.
EP. 2: Dr. Luckenbaugh looks back on testicular cancer/germ cell tumor research from ASCO 2022
Amy N. Luckenbaugh, MD, recaps 5 presentations from the 2022 American Society of Clinical Oncology Annual Meeting.
EP. 3: Dr. Tosoian recaps recent updates from pivotal prostate cancer trials
Jeffrey Tosoian, MD, MPH, recaps recent updates from the TheraP, ARAMIS, TITAN, ARASENS, and ATLAS prostate cancer trials.
Trial launches of diagnostic agent for clear cell renal cell carcinoma
The future of OAB treatment: Emerging nerve targets and AI may guide therapy
FDA expands Illuccix label to include patient selection for RLT in pre-taxane setting
FDA greenlights phase 1 trial of theranostic radiopharmaceutical for mCRPC
